Tilray Brands (TLRY) Total Debt Growth (1y) (2019 - 2025)
Tilray Brands (TLRY) Total Debt Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -0.14% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 37.52% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -92.65% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -9.19% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.63% |
| 10 | Tilray Brands | - | - | 54.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | -6.81% |
| Aug 31, 2025 | -5.75% |
| May 31, 2025 | -5.96% |
| Nov 30, 2024 | -49.96% |
| Aug 31, 2024 | 1.97% |
| May 31, 2024 | 8.01% |
| Feb 29, 2024 | 68.00% |
| Nov 30, 2023 | 66.56% |
| Aug 31, 2023 | 27.95% |
| May 31, 2023 | 18.36% |
| Feb 28, 2023 | -22.47% |
| Nov 30, 2022 | 11.25% |
| Aug 31, 2022 | -33.33% |
| May 31, 2022 | -22.82% |
| May 31, 2021 | 75.91% |
| Mar 31, 2020 | -10.94% |
| Sep 30, 2019 | 264.08% |